APO Research
Talk to an analyst

APO RESEARCH · REPORT

RNA Transcriptome Profiling Test

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global RNA Transcriptome Profiling Test Market Analysis and Forecast 2026-2032

15 April 2026194 pages

Choose your research edition.

Industry ResearchRNA Transcriptome Profiling Test Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal RNA Transcriptome Profiling Test Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal RNA Transcriptome Profiling Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RNA Transcriptome Profiling Test Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal RNA Transcriptome Profiling Test Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global RNA Transcriptome Profiling Test market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for RNA Transcriptome Profiling Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for RNA Transcriptome Profiling Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for RNA Transcriptome Profiling Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for RNA Transcriptome Profiling Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of RNA Transcriptome Profiling Test include Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Merck KGaA, Eurofins Scientific and Pacific Biosciences of California, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for RNA Transcriptome Profiling Test, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of RNA Transcriptome Profiling Test, also provides the revenue of main regions and countries. Of the upcoming market potential for RNA Transcriptome Profiling Test, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the RNA Transcriptome Profiling Test revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global RNA Transcriptome Profiling Test market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for RNA Transcriptome Profiling Test revenue, projected growth trends, production technology, application and end-user industry.

RNA Transcriptome Profiling Test Segment by Company

Thermo Fisher Scientific, Inc.

Illumina, Inc.

Agilent Technologies, Inc.

QIAGEN N.V.

F. Hoffmann-La Roche AG

Bio-Rad Laboratories, Inc.

Merck KGaA

Eurofins Scientific

Pacific Biosciences of California, Inc.

Promega Corporation

10x Genomics

Twist Bioscience

Bruker Spatial Biology

RNA Transcriptome Profiling Test Segment by Type

Consumables

Instruments

Software

Services

RNA Transcriptome Profiling Test Segment by Application

Hospital Based Laboratories

Diagnostic Centers

Academic and Research Institutes

Contract research Organizations (CROs)

Others

RNA Transcriptome Profiling Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Transcriptome Profiling Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RNA Transcriptome Profiling Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Transcriptome Profiling Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of RNA Transcriptome Profiling Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of RNA Transcriptome Profiling Test company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RNA Transcriptome Profiling Test revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global RNA Transcriptome Profiling Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Consumables Major Player Table 3. Instruments Major Player Table 4. Software Major Player Table 5. Services Major Player Table 6. Global RNA Transcriptome Profiling Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Based Laboratories Major Player Table 8. Diagnostic Centers Major Player Table 9. Academic and Research Institutes Major Player Table 10. Contract research Organizations (CROs) Major Player Table 11. Others Major Player Table 12. RNA Transcriptome Profiling Test Industry Trends Table 13. RNA Transcriptome Profiling Test Industry Drivers Table 14. RNA Transcriptome Profiling Test Industry Opportunities and Challenges Table 15. RNA Transcriptome Profiling Test Industry Restraints Table 16. Global RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global RNA Transcriptome Profiling Test Market Size by Region (2021-2026) & (US$ Million) Table 18. Global RNA Transcriptome Profiling Test Market Share by Region (2021-2026) Table 19. Global RNA Transcriptome Profiling Test Market Size by Region (2027-2032) & (US$ Million) Table 20. Global RNA Transcriptome Profiling Test Market Share by Region (2027-2032) Table 21. Global RNA Transcriptome Profiling Test Revenue by Players (US$ Million) & (2021-2026) Table 22. Global RNA Transcriptome Profiling Test Revenue Market Share by Players (2021-2026) Table 23. Global RNA Transcriptome Profiling Test Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global RNA Transcriptome Profiling Test Key Players Headquarters & Area Served Table 25. Global RNA Transcriptome Profiling Test Players, Product Type & Application Table 26. Global RNA Transcriptome Profiling Test Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global RNA Transcriptome Profiling Test by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global RNA Transcriptome Profiling Test Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global RNA Transcriptome Profiling Test Revenue by Type (2021-2026) & (US$ Million) Table 31. Global RNA Transcriptome Profiling Test Revenue by Type (2027-2032) & (US$ Million) Table 32. Global RNA Transcriptome Profiling Test Revenue Market Share by Type (2021-2026) Table 33. Global RNA Transcriptome Profiling Test Revenue Market Share by Type (2027-2032) Table 34. Global RNA Transcriptome Profiling Test Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global RNA Transcriptome Profiling Test Revenue by Application (2021-2026) & (US$ Million) Table 36. Global RNA Transcriptome Profiling Test Revenue by Application (2027-2032) & (US$ Million) Table 37. Global RNA Transcriptome Profiling Test Revenue Market Share by Application (2021-2026) Table 38. Global RNA Transcriptome Profiling Test Revenue Market Share by Application (2027-2032) Table 39. Thermo Fisher Scientific, Inc. Company Information Table 40. Thermo Fisher Scientific, Inc. Business Overview Table 41. Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 43. Thermo Fisher Scientific, Inc. Recent Development Table 44. Illumina, Inc. Company Information Table 45. Illumina, Inc. Business Overview Table 46. Illumina, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Illumina, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 48. Illumina, Inc. Recent Development Table 49. Agilent Technologies, Inc. Company Information Table 50. Agilent Technologies, Inc. Business Overview Table 51. Agilent Technologies, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Agilent Technologies, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 53. Agilent Technologies, Inc. Recent Development Table 54. QIAGEN N.V. Company Information Table 55. QIAGEN N.V. Business Overview Table 56. QIAGEN N.V. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. QIAGEN N.V. RNA Transcriptome Profiling Test Product Portfolio Table 58. QIAGEN N.V. Recent Development Table 59. F. Hoffmann-La Roche AG Company Information Table 60. F. Hoffmann-La Roche AG Business Overview Table 61. F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Product Portfolio Table 63. F. Hoffmann-La Roche AG Recent Development Table 64. Bio-Rad Laboratories, Inc. Company Information Table 65. Bio-Rad Laboratories, Inc. Business Overview Table 66. Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 68. Bio-Rad Laboratories, Inc. Recent Development Table 69. Merck KGaA Company Information Table 70. Merck KGaA Business Overview Table 71. Merck KGaA RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Merck KGaA RNA Transcriptome Profiling Test Product Portfolio Table 73. Merck KGaA Recent Development Table 74. Eurofins Scientific Company Information Table 75. Eurofins Scientific Business Overview Table 76. Eurofins Scientific RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Eurofins Scientific RNA Transcriptome Profiling Test Product Portfolio Table 78. Eurofins Scientific Recent Development Table 79. Pacific Biosciences of California, Inc. Company Information Table 80. Pacific Biosciences of California, Inc. Business Overview Table 81. Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 83. Pacific Biosciences of California, Inc. Recent Development Table 84. Promega Corporation Company Information Table 85. Promega Corporation Business Overview Table 86. Promega Corporation RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Promega Corporation RNA Transcriptome Profiling Test Product Portfolio Table 88. Promega Corporation Recent Development Table 89. 10x Genomics Company Information Table 90. 10x Genomics Business Overview Table 91. 10x Genomics RNA Transcriptome Profiling Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. 10x Genomics RNA Transcriptome Profiling Test Product Portfolio Table 93. 10x Genomics Recent Development Table 94. Twist Bioscience Company Information Table 95. Twist Bioscience Business Overview Table 96. Twist Bioscience RNA Transcriptome Profiling Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Twist Bioscience RNA Transcriptome Profiling Test Product Portfolio Table 98. Twist Bioscience Recent Development Table 99. Bruker Spatial Biology Company Information Table 100. Bruker Spatial Biology Business Overview Table 101. Bruker Spatial Biology RNA Transcriptome Profiling Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Bruker Spatial Biology RNA Transcriptome Profiling Test Product Portfolio Table 103. Bruker Spatial Biology Recent Development Table 104. North America RNA Transcriptome Profiling Test Revenue by Type (2021-2026) & (US$ Million) Table 105. North America RNA Transcriptome Profiling Test Revenue by Type (2027-2032) & (US$ Million) Table 106. North America RNA Transcriptome Profiling Test Revenue by Application (2021-2026) & (US$ Million) Table 107. North America RNA Transcriptome Profiling Test Revenue by Application (2027-2032) & (US$ Million) Table 108. North America RNA Transcriptome Profiling Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America RNA Transcriptome Profiling Test Revenue by Country (2021-2026) & (US$ Million) Table 110. North America RNA Transcriptome Profiling Test Revenue by Country (US$ Million) & (2027-2032) Table 111. Europe RNA Transcriptome Profiling Test Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe RNA Transcriptome Profiling Test Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe RNA Transcriptome Profiling Test Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe RNA Transcriptome Profiling Test Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe RNA Transcriptome Profiling Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Europe RNA Transcriptome Profiling Test Revenue by Country (2021-2026) & (US$ Million) Table 117. Europe RNA Transcriptome Profiling Test Revenue by Country (US$ Million) & (2027-2032) Table 118. China RNA Transcriptome Profiling Test Revenue by Type (2021-2026) & (US$ Million) Table 119. China RNA Transcriptome Profiling Test Revenue by Type (2027-2032) & (US$ Million) Table 120. China RNA Transcriptome Profiling Test Revenue by Application (2021-2026) & (US$ Million) Table 121. China RNA Transcriptome Profiling Test Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia RNA Transcriptome Profiling Test Revenue by Type (2021-2026) & (US$ Million) Table 123. Asia RNA Transcriptome Profiling Test Revenue by Type (2027-2032) & (US$ Million) Table 124. Asia RNA Transcriptome Profiling Test Revenue by Application (2021-2026) & (US$ Million) Table 125. Asia RNA Transcriptome Profiling Test Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia RNA Transcriptome Profiling Test Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Asia RNA Transcriptome Profiling Test Revenue by Region (US$ Million) & (2021-2026) Table 128. Asia RNA Transcriptome Profiling Test Revenue by Region (US$ Million) & (2027-2032) Table 129. SAMEA RNA Transcriptome Profiling Test Revenue by Type (2021-2026) & (US$ Million) Table 130. SAMEA RNA Transcriptome Profiling Test Revenue by Type (2027-2032) & (US$ Million) Table 131. SAMEA RNA Transcriptome Profiling Test Revenue by Application (2021-2026) & (US$ Million) Table 132. SAMEA RNA Transcriptome Profiling Test Revenue by Application (2027-2032) & (US$ Million) Table 133. SAMEA RNA Transcriptome Profiling Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. SAMEA RNA Transcriptome Profiling Test Revenue by Country (2021-2026) & (US$ Million) Table 135. SAMEA RNA Transcriptome Profiling Test Revenue by Country (US$ Million) & (2027-2032) Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. RNA Transcriptome Profiling Test Image Figure 2. Global RNA Transcriptome Profiling Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RNA Transcriptome Profiling Test Market Size Share 2021 VS 2025 VS 2032 Figure 4. Consumables Image Figure 5. Instruments Image Figure 6. Software Image Figure 7. Services Image Figure 8. Global RNA Transcriptome Profiling Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global RNA Transcriptome Profiling Test Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Based Laboratories Image Figure 11. Diagnostic Centers Image Figure 12. Academic and Research Institutes Image Figure 13. Contract research Organizations (CROs) Image Figure 14. Others Image Figure 15. Global RNA Transcriptome Profiling Test Market Size (US$ Million) & (2021-2032) Figure 16. Global RNA Transcriptome Profiling Test Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global RNA Transcriptome Profiling Test Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global RNA Transcriptome Profiling Test Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global RNA Transcriptome Profiling Test Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global RNA Transcriptome Profiling Test Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global RNA Transcriptome Profiling Test Revenue Market Share by Type (2021-2032) Figure 23. Global RNA Transcriptome Profiling Test Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global RNA Transcriptome Profiling Test Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global RNA Transcriptome Profiling Test Revenue Market Share by Application (2021-2032) Figure 26. North America RNA Transcriptome Profiling Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America RNA Transcriptome Profiling Test Revenue Share by Type (2021-2032) Figure 28. North America RNA Transcriptome Profiling Test Revenue Share by Application (2021-2032) Figure 29. North America RNA Transcriptome Profiling Test Revenue Share by Country (2021-2032) Figure 30. United States RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe RNA Transcriptome Profiling Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe RNA Transcriptome Profiling Test Revenue Share by Type (2021-2032) Figure 35. Europe RNA Transcriptome Profiling Test Revenue Share by Application (2021-2032) Figure 36. Europe RNA Transcriptome Profiling Test Revenue Share by Country (2021-2032) Figure 37. Germany RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China RNA Transcriptome Profiling Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China RNA Transcriptome Profiling Test Revenue Share by Type (2021-2032) Figure 47. China RNA Transcriptome Profiling Test Revenue Share by Application (2021-2032) Figure 48. Asia RNA Transcriptome Profiling Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia RNA Transcriptome Profiling Test Revenue Share by Type (2021-2032) Figure 50. Asia RNA Transcriptome Profiling Test Revenue Share by Application (2021-2032) Figure 51. Asia RNA Transcriptome Profiling Test Revenue Share by Region (2021-2032) Figure 52. Japan RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA RNA Transcriptome Profiling Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA RNA Transcriptome Profiling Test Revenue Share by Type (2021-2032) Figure 60. SAMEA RNA Transcriptome Profiling Test Revenue Share by Application (2021-2032) Figure 61. SAMEA RNA Transcriptome Profiling Test Revenue Share by Country (2021-2032) Figure 62. Brazil RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt RNA Transcriptome Profiling Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Consumables
  • Instruments
  • Software
  • Services
Applications
  • Hospital Based Laboratories
  • Diagnostic Centers
  • Academic and Research Institutes
  • Contract research Organizations (CROs)
  • Others
Companies covered
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Eurofins Scientific
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • 10x Genomics
  • Twist Bioscience
  • Bruker Spatial Biology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 RNA Transcriptome Profiling Test Market by Type
  3. 1.2.1 Global RNA Transcriptome Profiling Test Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Consumables
  5. 1.2.3 Instruments
  6. 1.2.4 Software
  7. 1.2.5 Services
  8. 1.3 RNA Transcriptome Profiling Test Market by Application
  9. 1.3.1 Global RNA Transcriptome Profiling Test Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital Based Laboratories
  11. 1.3.3 Diagnostic Centers
  12. 1.3.4 Academic and Research Institutes
  13. 1.3.5 Contract research Organizations (CROs)
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 RNA Transcriptome Profiling Test Market Dynamics
  1. 2.1 RNA Transcriptome Profiling Test Industry Trends
  2. 2.2 RNA Transcriptome Profiling Test Industry Drivers
  3. 2.3 RNA Transcriptome Profiling Test Industry Opportunities and Challenges
  4. 2.4 RNA Transcriptome Profiling Test Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global RNA Transcriptome Profiling Test Market Perspective (2021-2032)
  2. 3.2 Global RNA Transcriptome Profiling Test Growth Trends by Region
  3. 3.2.1 Global RNA Transcriptome Profiling Test Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global RNA Transcriptome Profiling Test Market Size by Region (2021-2026)
  5. 3.2.3 Global RNA Transcriptome Profiling Test Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global RNA Transcriptome Profiling Test Revenue by Players
  2. 4.1.1 Global RNA Transcriptome Profiling Test Revenue by Players (2021-2026)
  3. 4.1.2 Global RNA Transcriptome Profiling Test Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global RNA Transcriptome Profiling Test Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global RNA Transcriptome Profiling Test Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global RNA Transcriptome Profiling Test Key Players Headquarters & Area Served
  7. 4.4 Global RNA Transcriptome Profiling Test Players, Product Type & Application
  8. 4.5 Global RNA Transcriptome Profiling Test Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global RNA Transcriptome Profiling Test Market CR5 and HHI
  11. 4.6.3 2025 RNA Transcriptome Profiling Test Tier 1, Tier 2, and Tier 3
5 RNA Transcriptome Profiling Test Market Size by Type
  1. 5.1 Global RNA Transcriptome Profiling Test Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global RNA Transcriptome Profiling Test Revenue by Type (2021-2032)
  3. 5.3 Global RNA Transcriptome Profiling Test Revenue Market Share by Type (2021-2032)
6 RNA Transcriptome Profiling Test Market Size by Application
  1. 6.1 Global RNA Transcriptome Profiling Test Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global RNA Transcriptome Profiling Test Revenue by Application (2021-2032)
  3. 6.3 Global RNA Transcriptome Profiling Test Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific, Inc.
  2. 7.1.1 Thermo Fisher Scientific, Inc. Company Information
  3. 7.1.2 Thermo Fisher Scientific, Inc. Business Overview
  4. 7.1.3 Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific, Inc. Recent Developments
  7. 7.2 Illumina, Inc.
  8. 7.2.1 Illumina, Inc. Company Information
  9. 7.2.2 Illumina, Inc. Business Overview
  10. 7.2.3 Illumina, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Illumina, Inc. RNA Transcriptome Profiling Test Product Portfolio
  12. 7.2.5 Illumina, Inc. Recent Developments
  13. 7.3 Agilent Technologies, Inc.
  14. 7.3.1 Agilent Technologies, Inc. Company Information
  15. 7.3.2 Agilent Technologies, Inc. Business Overview
  16. 7.3.3 Agilent Technologies, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Agilent Technologies, Inc. RNA Transcriptome Profiling Test Product Portfolio
  18. 7.3.5 Agilent Technologies, Inc. Recent Developments
  19. 7.4 QIAGEN N.V.
  20. 7.4.1 QIAGEN N.V. Company Information
  21. 7.4.2 QIAGEN N.V. Business Overview
  22. 7.4.3 QIAGEN N.V. RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  23. 7.4.4 QIAGEN N.V. RNA Transcriptome Profiling Test Product Portfolio
  24. 7.4.5 QIAGEN N.V. Recent Developments
  25. 7.5 F. Hoffmann-La Roche AG
  26. 7.5.1 F. Hoffmann-La Roche AG Company Information
  27. 7.5.2 F. Hoffmann-La Roche AG Business Overview
  28. 7.5.3 F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  29. 7.5.4 F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Product Portfolio
  30. 7.5.5 F. Hoffmann-La Roche AG Recent Developments
  31. 7.6 Bio-Rad Laboratories, Inc.
  32. 7.6.1 Bio-Rad Laboratories, Inc. Company Information
  33. 7.6.2 Bio-Rad Laboratories, Inc. Business Overview
  34. 7.6.3 Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Product Portfolio
  36. 7.6.5 Bio-Rad Laboratories, Inc. Recent Developments
  37. 7.7 Merck KGaA
  38. 7.7.1 Merck KGaA Company Information
  39. 7.7.2 Merck KGaA Business Overview
  40. 7.7.3 Merck KGaA RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Merck KGaA RNA Transcriptome Profiling Test Product Portfolio
  42. 7.7.5 Merck KGaA Recent Developments
  43. 7.8 Eurofins Scientific
  44. 7.8.1 Eurofins Scientific Company Information
  45. 7.8.2 Eurofins Scientific Business Overview
  46. 7.8.3 Eurofins Scientific RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Eurofins Scientific RNA Transcriptome Profiling Test Product Portfolio
  48. 7.8.5 Eurofins Scientific Recent Developments
  49. 7.9 Pacific Biosciences of California, Inc.
  50. 7.9.1 Pacific Biosciences of California, Inc. Company Information
  51. 7.9.2 Pacific Biosciences of California, Inc. Business Overview
  52. 7.9.3 Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Product Portfolio
  54. 7.9.5 Pacific Biosciences of California, Inc. Recent Developments
  55. 7.10 Promega Corporation
  56. 7.10.1 Promega Corporation Company Information
  57. 7.10.2 Promega Corporation Business Overview
  58. 7.10.3 Promega Corporation RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Promega Corporation RNA Transcriptome Profiling Test Product Portfolio
  60. 7.10.5 Promega Corporation Recent Developments
  61. 7.11 10x Genomics
  62. 7.11.1 10x Genomics Company Information
  63. 7.11.2 10x Genomics Business Overview
  64. 7.11.3 10x Genomics RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  65. 7.11.4 10x Genomics RNA Transcriptome Profiling Test Product Portfolio
  66. 7.11.5 10x Genomics Recent Developments
  67. 7.12 Twist Bioscience
  68. 7.12.1 Twist Bioscience Company Information
  69. 7.12.2 Twist Bioscience Business Overview
  70. 7.12.3 Twist Bioscience RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Twist Bioscience RNA Transcriptome Profiling Test Product Portfolio
  72. 7.12.5 Twist Bioscience Recent Developments
  73. 7.13 Bruker Spatial Biology
  74. 7.13.1 Bruker Spatial Biology Company Information
  75. 7.13.2 Bruker Spatial Biology Business Overview
  76. 7.13.3 Bruker Spatial Biology RNA Transcriptome Profiling Test Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Bruker Spatial Biology RNA Transcriptome Profiling Test Product Portfolio
  78. 7.13.5 Bruker Spatial Biology Recent Developments
8 North America
  1. 8.1 North America RNA Transcriptome Profiling Test Revenue (2021-2032)
  2. 8.2 North America RNA Transcriptome Profiling Test Revenue by Type (2021-2032)
  3. 8.2.1 North America RNA Transcriptome Profiling Test Revenue by Type (2021-2026)
  4. 8.2.2 North America RNA Transcriptome Profiling Test Revenue by Type (2027-2032)
  5. 8.3 North America RNA Transcriptome Profiling Test Revenue Share by Type (2021-2032)
  6. 8.4 North America RNA Transcriptome Profiling Test Revenue by Application (2021-2032)
  7. 8.4.1 North America RNA Transcriptome Profiling Test Revenue by Application (2021-2026)
  8. 8.4.2 North America RNA Transcriptome Profiling Test Revenue by Application (2027-2032)
  9. 8.5 North America RNA Transcriptome Profiling Test Revenue Share by Application (2021-2032)
  10. 8.6 North America RNA Transcriptome Profiling Test Revenue by Country
  11. 8.6.1 North America RNA Transcriptome Profiling Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America RNA Transcriptome Profiling Test Revenue by Country (2021-2026)
  13. 8.6.3 North America RNA Transcriptome Profiling Test Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe RNA Transcriptome Profiling Test Revenue (2021-2032)
  2. 9.2 Europe RNA Transcriptome Profiling Test Revenue by Type (2021-2032)
  3. 9.2.1 Europe RNA Transcriptome Profiling Test Revenue by Type (2021-2026)
  4. 9.2.2 Europe RNA Transcriptome Profiling Test Revenue by Type (2027-2032)
  5. 9.3 Europe RNA Transcriptome Profiling Test Revenue Share by Type (2021-2032)
  6. 9.4 Europe RNA Transcriptome Profiling Test Revenue by Application (2021-2032)
  7. 9.4.1 Europe RNA Transcriptome Profiling Test Revenue by Application (2021-2026)
  8. 9.4.2 Europe RNA Transcriptome Profiling Test Revenue by Application (2027-2032)
  9. 9.5 Europe RNA Transcriptome Profiling Test Revenue Share by Application (2021-2032)
  10. 9.6 Europe RNA Transcriptome Profiling Test Revenue by Country
  11. 9.6.1 Europe RNA Transcriptome Profiling Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe RNA Transcriptome Profiling Test Revenue by Country (2021-2026)
  13. 9.6.3 Europe RNA Transcriptome Profiling Test Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China RNA Transcriptome Profiling Test Revenue (2021-2032)
  2. 10.2 China RNA Transcriptome Profiling Test Revenue by Type (2021-2032)
  3. 10.2.1 China RNA Transcriptome Profiling Test Revenue by Type (2021-2026)
  4. 10.2.2 China RNA Transcriptome Profiling Test Revenue by Type (2027-2032)
  5. 10.3 China RNA Transcriptome Profiling Test Revenue Share by Type (2021-2032)
  6. 10.4 China RNA Transcriptome Profiling Test Revenue by Application (2021-2032)
  7. 10.4.1 China RNA Transcriptome Profiling Test Revenue by Application (2021-2026)
  8. 10.4.2 China RNA Transcriptome Profiling Test Revenue by Application (2027-2032)
  9. 10.5 China RNA Transcriptome Profiling Test Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia RNA Transcriptome Profiling Test Revenue (2021-2032)
  2. 11.2 Asia RNA Transcriptome Profiling Test Revenue by Type (2021-2032)
  3. 11.2.1 Asia RNA Transcriptome Profiling Test Revenue by Type (2021-2026)
  4. 11.2.2 Asia RNA Transcriptome Profiling Test Revenue by Type (2027-2032)
  5. 11.3 Asia RNA Transcriptome Profiling Test Revenue Share by Type (2021-2032)
  6. 11.4 Asia RNA Transcriptome Profiling Test Revenue by Application (2021-2032)
  7. 11.4.1 Asia RNA Transcriptome Profiling Test Revenue by Application (2021-2026)
  8. 11.4.2 Asia RNA Transcriptome Profiling Test Revenue by Application (2027-2032)
  9. 11.5 Asia RNA Transcriptome Profiling Test Revenue Share by Application (2021-2032)
  10. 11.6 Asia RNA Transcriptome Profiling Test Revenue by Country
  11. 11.6.1 Asia RNA Transcriptome Profiling Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia RNA Transcriptome Profiling Test Revenue by Country (2021-2026)
  13. 11.6.3 Asia RNA Transcriptome Profiling Test Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA RNA Transcriptome Profiling Test Revenue (2021-2032)
  2. 12.2 SAMEA RNA Transcriptome Profiling Test Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA RNA Transcriptome Profiling Test Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA RNA Transcriptome Profiling Test Revenue by Type (2027-2032)
  5. 12.3 SAMEA RNA Transcriptome Profiling Test Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA RNA Transcriptome Profiling Test Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA RNA Transcriptome Profiling Test Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA RNA Transcriptome Profiling Test Revenue by Application (2027-2032)
  9. 12.5 SAMEA RNA Transcriptome Profiling Test Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA RNA Transcriptome Profiling Test Revenue by Country
  11. 12.6.1 SAMEA RNA Transcriptome Profiling Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA RNA Transcriptome Profiling Test Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA RNA Transcriptome Profiling Test Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst